| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/08/2008 | US7354900 Also bactericidal or bacteriostatic contact lens coated with the peptide |
| 04/08/2008 | US7354896 Suspension containing milk fat spheres; therapy for infant weight diseases |
| 04/08/2008 | US7354759 Induce immunology response; antiproliferation agents; coding immoglobulins |
| 04/08/2008 | US7354603 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 04/08/2008 | US7354602 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
| 04/08/2008 | US7354601 Particulate materials |
| 04/08/2008 | US7354600 Thiolated copolymer of acrylic acid and divinyl glycol or a thiolated polymer of chitosan, sodium carboxymethylcellulose, sodium alginate, sodium hydroxypropylcellulose, hyaluronic acid, or pectin with nonterminal thiol groups; total work of adhesion of more than 120 mu J to intestinal mucosa at pH of 7 |
| 04/08/2008 | US7354599 Storage stability; freeze drying; mixture containing phospholipids and monosaccharides; regenerated as aqueous solution;administering by injection |
| 04/08/2008 | US7354598 in one embodiment, a paper towel roll can have a wet wipes container located within the core of the towel roll occupying the previously unutilized interior space |
| 04/08/2008 | US7354597 Microscale lyophilization and drying methods for the stabilization of molecules |
| 04/08/2008 | US7354576 Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase |
| 04/08/2008 | US7354574 Treatment of ocular disease |
| 04/08/2008 | US7354569 Mixture containing plaque reducing enzyme and artificial sweetener |
| 04/08/2008 | CA2445086C Hydrogel compositions |
| 04/08/2008 | CA2394699C Device for injection of antiparasitic agents in domestic animals |
| 04/08/2008 | CA2384739C Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 04/08/2008 | CA2337886C Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 04/08/2008 | CA2316887C Osmotic drug delivery monitoring system and method |
| 04/08/2008 | CA2304819C Perforated microparticles and methods of use |
| 04/08/2008 | CA2295588C Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 04/08/2008 | CA2274565C Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
| 04/08/2008 | CA2273298C Product and method for the treatment of hyperlipidemia |
| 04/08/2008 | CA2271126C Method of treating bronchitis with uridine triphosphates and related compounds |
| 04/08/2008 | CA2260909C Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 04/08/2008 | CA2256369C A process for encapsulating viable animal cells |
| 04/08/2008 | CA2231342C Pharmaceutical composition for oral delivery |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/06/2008 | CA2605902A1 Devices for reduction of post operative ileus |
| 04/06/2008 | CA2562821A1 Composition and method for raising blood glucose level |
| 04/03/2008 | WO2008039989A2 Formulations of dnase and methods of use thereof |
| 04/03/2008 | WO2008039987A2 Methods of treating pulmonary distress |
| 04/03/2008 | WO2008039914A2 Sic single crystals with reduced dislocation density grown by step-wise periodic perturbation technique |
| 04/03/2008 | WO2008039894A2 Atorvastatin pharmaceutical compositions |
| 04/03/2008 | WO2008039864A1 Emulsion formulations for transdermal delivery of poorly water soluble active agents |
| 04/03/2008 | WO2008039737A2 A method of administering a film product containing a drug |
| 04/03/2008 | WO2008039698A1 Multi-core solid dosage form comprising a transparent coating between said cores |
| 04/03/2008 | WO2008039615A2 Controlled release hydrogel formulation |
| 04/03/2008 | WO2008039531A1 Probiotic oral dosage forms |
| 04/03/2008 | WO2008039472A2 Stabilizing compositions for antibiotics and methods of use |
| 04/03/2008 | WO2008039358A2 Resin-complex granulation for water-soluble drugs and associated methods |
| 04/03/2008 | WO2008039351A2 Method of manufacturing tablets containing pharmacologically active agents |
| 04/03/2008 | WO2008039291A2 Dosage forms for tamper prone therapeutic agents |
| 04/03/2008 | WO2008039188A1 Method of treating cancer comprising introduction of heat and delivery of liposome containing an active agent or thermo-activated drug, gene or virus to tissue |
| 04/03/2008 | WO2008038944A1 Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| 04/03/2008 | WO2008038939A1 Preparation and composition of meloxicam transdermal drug delivery system |
| 04/03/2008 | WO2008038292A2 Use of glycerophospholipids for joint lubrication |
| 04/03/2008 | WO2008038291A1 Combination of liposomal anti-cancer drugs and lysosome/endosome ph increasing agents for therapy |
| 04/03/2008 | WO2008038241A2 Electrically activated gel array for transdermal drug delivery |
| 04/03/2008 | WO2008038155A2 Controlled-release pharmaceutical tablets |
| 04/03/2008 | WO2008038106A1 Venlafaxine extended release formulations |
| 04/03/2008 | WO2008038007A2 Method of separating carbon nanotubes |
| 04/03/2008 | WO2008038003A2 Pharmaceutical compositions of aripiprazole |
| 04/03/2008 | WO2008037809A1 Transmucosal administration of fibrate compounds and delivery system therefor |
| 04/03/2008 | WO2008037807A1 Pharmaceutical formulation comprising metformin and repaglinide |
| 04/03/2008 | WO2008037716A2 Pharmaceutical compositions comprising nilotinib or its salt |
| 04/03/2008 | WO2008037557A2 Rapidly solubilising formulation of non-steroidal anti-inflammatory drugs |
| 04/03/2008 | WO2008037555A1 Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof |
| 04/03/2008 | WO2008037421A2 Pharmaceutical compositions comprising an s1p modulator |
| 04/03/2008 | WO2008037252A1 Chewing gum comprising hvdroxyapatite |
| 04/03/2008 | WO2008037182A1 Use of ginsenoside rg1 for treatment of cerebral ischemia and/or diseases or symptoms induced by cerebral ischemia |
| 04/03/2008 | WO2008037176A1 Transdermal preparations comprising artemisinin and/or its derivatives |
| 04/03/2008 | WO2008037044A1 Oxcarbazepine-containing oral formulation and a process to obtain the same |
| 04/03/2008 | WO2008021124A3 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
| 04/03/2008 | WO2008016165A3 Liquid preparation |
| 04/03/2008 | WO2008015220A8 Granule and orally disintegrating tablet comprising oxycodone |
| 04/03/2008 | WO2008013807A3 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 04/03/2008 | WO2008012725A3 A drug delivery system with thermoswitchable membranes |
| 04/03/2008 | WO2008012465A3 Granulated sorbitol and method for the preparation thereof |
| 04/03/2008 | WO2008008468A3 Compositions and methods for fat reduction |
| 04/03/2008 | WO2008006226A8 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 04/03/2008 | WO2008001204A3 Transdermal compositions of pramipexole having enhanced permeation properties |
| 04/03/2008 | WO2008000731A3 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 04/03/2008 | WO2007145909A3 Methods and compositions for treating post-myocardial infarction damage |
| 04/03/2008 | WO2007142548A3 Vesicular formulations containing organic acid prodrugs, process for their preparation |
| 04/03/2008 | WO2007126494A3 Coatings formed from stimulus-sensitive material |
| 04/03/2008 | WO2007119028A3 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 04/03/2008 | WO2007107878A3 Solid dosage forms of hypnotic agent |
| 04/03/2008 | WO2007089582A3 Lipoparticles comprising ion channels, methods of making, and using the same |
| 04/03/2008 | WO2007087452A3 Abuse resistant and extended release formulations and method of use thereof |
| 04/03/2008 | WO2007086079B1 Sustained release dosage form of phenothiazine derivatives containing channelizer |
| 04/03/2008 | WO2007081948A3 Bioadhesive drug formulations for oral transmucosal delivery |
| 04/03/2008 | WO2007075871A3 Processes for reducing particle size of aripiprazole |
| 04/03/2008 | US20080083041 Pre-Clinical Animal Testing Method |
| 04/03/2008 | US20080082120 Introducer assembly and method for forming an introducer assembly |
| 04/03/2008 | US20080081801 8,13-bisvinyl-2-methyl aminocarbonylethyl-18-(3-(1-imidazolyl)propylamino)carbonyl ethyl-3,7,12,17 tetramethylporphyrin iron complex; albumin clathrate; decreases radiation resistance of hypoxic region of the tumor tissues; highly safe |
| 04/03/2008 | US20080081796 Treatment of mucositis |
| 04/03/2008 | US20080081787 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 04/03/2008 | US20080081156 Storage wrap material |
| 04/03/2008 | US20080081075 Graft macromolecule such as N-isopropylacrylamide-methacrylic acid copolymer with aggregated hydrophobic side chains; block copolymer such as methoxy-ethylene glycol-lactic acid copolymer; extruded to form a shell-core polymer; cancer diagnosis and drug delivery carriers; bioresorbable; self-assembled |
| 04/03/2008 | US20080081074 Polymers for functional particles |
| 04/03/2008 | US20080081073 Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease |
| 04/03/2008 | US20080081072 Resin-complex granulation for water-soluble drugs and associated methods |
| 04/03/2008 | US20080081071 Pouch for drug delivery comprising a porous semipermeable substrate; and water soluble film at least partially embedded; food, nutraceuticals, cosmetics |
| 04/03/2008 | US20080081070 Pharmaceutical formulation with enhanced solubility for the delivery of corticosteroids |
| 04/03/2008 | US20080081069 Novel controlled release formulations of divalproex sodium |
| 04/03/2008 | US20080081068 Modified release formulations of a bupropion salt |
| 04/03/2008 | US20080081067 First sustained release portion of core with functional coating; second portion with core and separator with functional coating; excipients; treating depressive, anxiety, and panic disorder; rate controlling polymer of ethyl acrylate, methyl methacrylate and trimethylammonioethyl methacrylate |
| 04/03/2008 | US20080081066 Reducing blood pressure byorally administering a mixture of L-theanine and a tea polyphenol such as epigallocatechol gallate; antiinflammatory and hypotensive agents; reducing low density lipoproteins |
| 04/03/2008 | US20080081065 Materials and methods for inhibiting wip1 |
| 04/03/2008 | US20080081062 Contacting medical device having surface formed from a swellable macromolecular substance with antibiotic such as isepamicin sulfate, amikacin sulfate, tobramycin, and/or kitasamycin tartrate; desolventizing |